by Stuart Titus, CEO
On behalf of Medical Marijuana Inc. (OTC: MJNA), I’m very excited that our portfolio company, KannaLife™ Sciences, Inc. is part of the CNN special Weed 3: The Marijuana Revolution with Dr. Sanjay Gupta.
Having been a Board Member of KannaLife™ for many years now, I am excited to see that the Company is receiving this deserved attention in the press and media. The early-stage research has been phenomenal which gives us great confidence that a future pharmaceutical product will usher in a new era for therapies involving nerve and neurological conditions. The recent addition of Dr. Bennet Omalu to the KannaLife™ Scientific Advisory Board shows that the scientific community feels there may be help on the way for long time sufferers – including those with CTE.
If you’d like to learn more about the special, please visit CNN’s page about it here.
KannaLife™ Sciences Inc. (www.kannalife.com) is a late stage biotechnology development company currently in pharmaceutical development of novel therapeutic agents designed for neuro-protection and neuro-modulation. The company holds two license agreements with the National Institutes of Health (NIH) to utilize the US Government Patent (#6,630,507) on the therapeutic usage of cannabinoids, which derive from the cannabis plant family (industrial hemp or marijuana).
KannaLife™ is presently conducting research at the Pennsylvania Biotechnology Center in Doylestown PA for target drug candidates to treat Hepatic Encephalopathy (HE) as well as Chronic Traumatic Encephalopathy (CTE). Both are oxidative stress diseases that affect cognitive and behavioral function.
Acute, late-stage CTE is a form of encephalopathy that has been found in professional athletes participating in contact and collision sports. The long term effects of repetitive brain trauma and concussive head injury have also been found in military men and women who have been exposed to a blast or concussive injury. Individuals with CTE may show symptoms of dementia, such as memory loss, aggression, confusion and depression, which generally appear years or decades after the trauma.
Dr. Omalu, a pathologist, was the first researcher to identify, describe and name CTE as a disease entity in football players and wrestlers. Dr. Omalu has testified twice before the United States Congress and has provided hundreds of testimonies as an expert witness in federal and state courts across the United States. Dr. Omalu is the focal point of the highly acclaimed PBS FRONTLINE documentary League of Denial. http://www.pbs.org/wgbh/pages/frontline/league-of-denial/ .
More info on Dr. Omalu: www.bennetomalu.com